Class A G-protein-coupled receptors (GPCRs) are a large family of membrane proteins that mediate a wide variety of physiological functions, including vision, neurotransmission and immune responses 1-4 . They are the targets of nearly onethird of all prescribed medicinal drugs 5 such as beta blockers and antipsychotics. GPCR activation is facilitated by extracellular ligands and leads to the recruitment of intracellular G proteins 3, 6 . Structural rearrangements of residue contacts in the transmembrane domain serve as 'activation pathways' that connect the ligandbinding pocket to the G-protein-coupling region within the receptor. In order to investigate the similarities in activation pathways across class A GPCRs, we analysed 27 GPCRs from diverse subgroups for which structures of active, inactive or both states were available. Here we show that, despite the diversity in activation pathways between receptors, the pathways converge near the G-proteincoupling region. This convergence is mediated by a highly conserved structural rearrangement of residue contacts between transmembrane helices 3, 6 and 7 that releases G-protein-contacting residues. The convergence of activation pathways may explain how the activation steps initiated by diverse ligands enable GPCRs to bind a common repertoire of G proteins.
. The activated receptor binds to G proteins and allosterically activates them [14] [15] [16] [17] . In this manner, the GPCR transmembrane region enables the transmission of signals across the cell membrane. At the time of writing, crystal structures have been determined for 27 class A GPCRs, belonging to seven of the eleven different subgroups (which are defined by the endogenous ligand types they bind; GPCRdb 18 ; http://www.gpcrdb.org). Whereas most structures correspond to inactive states (those bound to an antagonist or inverse agonist), some structures of receptors in active states (bound to an agonist and with structural rearrangements at the G-protein-binding region) have also been solved. There are five receptors for which the structures of both inactive and active (that is, active or active-intermediate) states are available: light-activated rhodopsin 8, 13 , the amineactivated β 2 -adrenergic receptor (β 2 AR) 7 , the M2 muscarinic receptor (M2R) 11 , the nucleoside-activated A 2A receptor (A 2A R) 12 and the peptide-activated μ -opioid receptor (μ OR) 10 . The remaining structures have been determined only in either their inactive or active states. The availability of GPCR structures from divergent subgroups (some with a sequence identity as low as around 20% 19 ) that are bound to chemically diverse ligands, and known to couple to different G proteins, allowed us to investigate activation pathways across class A GPCRs.
As GPCRs are structurally similar and activate a small set of G proteins, some structural aspects of receptor activation, such as contraction of the ligand-binding site or opening of the cytosolic side owing to relocation of transmembrane helix 6 (TM6), are broadly similar. However, receptor activation is mediated by diverse ligands and therefore some aspects of ligand-associated GPCR activation must necessarily be receptor-specific. To assess the similarity of activation pathways across different receptors, we carried out a comprehensive comparison of residue contacts of inactive and active state structures. Structural equivalence for residues across the different GPCRs was assigned using the GPCR database numbering scheme 20 from GPCRdb 18 (further details in Methods). A contact between a pair of residues is said to exist if the interatomic distance between any two atoms across the residue pair is shorter than the sum of their van der Waals radii plus a cut-off distance 4, 14 ( Fig. 1a ; further details in Methods). Analysis of residue contacts in the inactive-and active-state structures of rhodopsin, β 2 AR, M2R, A 2A R and μ OR revealed that there are 220-266 contacts between residues in the seven transmembrane helices and helix 8 for each receptor (Fig. 1b) . In every receptor, roughly half of the residue contacts are reorganized upon activation.
The combinatorial possibilities of structural comparisons of multiple receptors make it difficult to determine the similarities in contacts that change upon activation among different receptors. Therefore, we used an unbiased, multi-way comparison approach in which we analysed the pattern of contacts between structurally equivalent residues across all inactive and active state structures (termed the contact fingerprint; Fig. 2a ). Of the 451 contact fingerprints, only 30 represent contacts that are maintained consistently in all inactive-and/or active-state structures. The remaining 421 contact fingerprints represent contacts that are not maintained consistently in the inactive-or active-state structures across the five GPCRs. This suggests that there is marked diversity in the activation pathways of the different receptors (Fig. 2b) .
Despite the diversity in the reorganization of residue contacts upon receptor activation, four contacts involving seven residues are exclusively maintained in all inactive-state structures and two contacts involving four residues are maintained exclusively in all active-state structures ( Fig. 3 and Supplementary Table 1) . When the roles of these contacts in the inactive-and active-state structures are considered together, a common re-organization of contacts upon activation becomes apparent, involving residue positions 3x46 in TM3, 6x37 in TM6 and 7x53 in TM7 (notation represents the GPCRdb numbering scheme) (Fig. 3) . These contacts are proximal to the G proteincoupling region and therefore distant from the ligand-binding pocket. This finding highlights that the diverse structural changes among the LETTER RESEARCH receptors, which are stabilized by a range of different ligands, converge on a common set of rearrangements near the G-protein-coupling region.
Upon receptor activation, the cytoplasmic side of TM6 moves away from the rest of the transmembrane bundle, making several previously inaccessible G-protein-coupling residues accessible 7 . Many of these residues participate in triggering the conserved allosteric mechanism for GDP release in G proteins 14 . These include position 6x37 in the cytoplasmic end of TM6, which, upon activation, contacts a universally conserved leucine (position G.H5.25; notation taken from the Common G protein numbering scheme 14 ) of the G protein in the β 2 AR-G s structure (Fig. 4a) . In its inactive state, the residue at 6x37 is engaged in a residue contact with a conserved hydrophobic residue at position 3x46 (Fig. 4a) . Upon activation, the residue at 3x46 breaks the contact with the one at 6x37 and forms a new contact with a tyrosine residue, Tyr7x53, within the highly conserved NPXXY motif of TM7. In the inactive state, Tyr7x53 is not available to engage with 3x46 because TM7 and TM3 are far apart and require TM6 to move out in order to form a contact. The residues at position 8x50 and 1x53 contact the residue at 7x53 in the inactive state, and both contacts are lost upon receptor activation. This contact rearrangement is observed consistently in each of the five GPCRs examined, even though they are from different GPCR subgroups, bind to different ligands and couple to different G proteins. Thus, despite the diversity in contact reorganization upon activation (Fig. 2b) , there exists a common rearrangement of residue contacts near the G-protein-coupling site that underlies the activation of diverse class A GPCRs (Fig. 4a) .
To assess the consistency of the contacts between residues 3x46, 6x37 and 7x53, we investigated all the other class A GPCR structures that were available only in either the inactive or activate state (further details in Methods). These include functionally diverse receptors belonging to seven of the eleven subgroups of class A GPCRs: light-activated opsins, aminergic receptors, peptide-binding receptors, protein-binding receptors, nucleoside-binding receptors, lipid-binding receptors, and others (Fig. 4b) . The contact between 3x46 and 6x37 is present consistently in all inactive state structures but in none of the active state structures (Fig. 4b) . Similarly, the contact between 3x46 and 7x53 is present consistently in all active-state structures but in none of the inactive-state structures (Fig. 4b) . To investigate the importance of these residue positions and contacts for class A GPCRs (including in those that lack a solved structure), we performed a sequence analysis of all human non-olfactory class A GPCRs. We found that the residues that mediate contacts tend to be predominantly large hydrophobic or aromatic residues and therefore are likely to fulfil the distance criterion for contact formation (Extended Data Fig. 1 ). Together, these observations suggest that the rearrangement of contacts involving positions 3x46, 6x37 and 7x53 is likely to be conserved and important for receptor activation in all class A GPCRs.
In order to investigate experimentally the importance of the interactions between 3x46, 6x37 and 7x53 in a receptor for which there is no crystal structure available, we examined the signalling profile of the V2 vasopressin receptor using BRET signalling assays 21, 22 . We created single-, double-and triple-alanine mutants at these positions and measured vasopressin-induced G s and G q activation to assess LETTER RESEARCH receptor function. The mutations resulted in markedly reduced ability of the receptor to activate G s and G q when compared to the wild-type receptor (Extended Data Fig. 2 ). Previous observations from mutagenesis experiments in other GPCRs also highlight the importance of these positions for signalling (Supplementary Table 2 ). For instance, mutation of 6x37 in α 1b -AR results in a reduction of more than 70% in downstream signalling 23 . Similarly, mutation of Tyr7x53 in β 2 AR leads to a significant reduction in G protein activation 24 . The nature of the substitution is likely to influence how the receptor is affected 25 . Given the key role of these residues, a mutation in one of these positions is likely to disrupt functional integrity, which could lead to a pathological condition in a physiological context. Indeed, mutations at these positions in different GPCRs are associated with disease (an example being hypogonadotropic hypogonadism 26 ; more can be found in Supplementary Table 3 ). Given the importance of positions 3x46, 6x37 and 7x53 in diverse GPCRs, we anticipate that knowledge about the conserved rearrangement of contacts will guide GPCR modelling and simulations, facilitate engineering of GPCRs and help researchers to identify disease-causing mutations in other receptors.
Several studies have provided insights into distinct mechanisms of activation in individual receptors [7] [8] [9] [10] [11] [12] [13] , and have described networks of contacts that are present in various combinations in different receptors upon activation 4, 10, 27, 28 . Here we report a highly conserved rearrangement of specific residue contacts that functions as a common step in the activation pathways of diverse class A GPCRs. Because the microenvironment (that is, the surrounding residues and second shell residues) in which this rearrangement takes place diverges among receptor families, the detailed mechanism by which this common step is facilitated is likely to be distinct for different sets of GPCRs. Despite such differences, we find that the activation pathways ultimately converge onto a conserved, specific set of contact rearrangements between topologically Inactive-statespeci c contacts Active-statespeci c contacts   TM6   TM1  TM7 H8   TM3   N   C   TM1  TM2   TM3   TM4   TM5   TM6   TM7  H8   TM1  TM2   TM3   TM4   TM5   TM6   TM7   H8   C   N   TM5   TM6   TM7 LETTER RESEARCH equivalent residues near the G-protein-coupling region. Future studies aimed at investigating residues at and around these positions will help to uncover the steps that lead to the triggering of this convergent reorganization in a receptor-and ligand-specific manner.
From an evolutionary perspective, uncoupling the structural changes near the ligand-binding pocket from the G-protein-coupling region permits the ligand-binding pocket to evolve independently of the intracellular region that couples to G proteins, whilst ensuring that the activation pathways converge near the G-protein-coupling site. In this manner, the convergence of ligand-mediated allosteric activation pathways may have contributed to the evolutionary success of GPCRs: their ability to bind and be activated by a plethora of ligands, but to signal intracellularly via a small repertoire of signalling proteins inside the cell.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
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METHODS
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Data set. The coordinates of the crystal structures of 27 GPCRs were obtained from the Protein Data Bank 29 (PDB; http://www.rcsb.org). The structures were classified into either inactive or active (active/active-intermediate) states. An inactivestate structure is one that is bound to an antagonist or an inverse agonist. An active-state structure is one bound to an agonist and has undergone structural rearrangements in the G-protein-coupling region in comparison to its inactive state structure.
There are inactive-state structures for the following GPCRs: rhodopsin (PDB accession code 1GZM), invertebrate rhodopsin (2Z73), β 1 -adrenergic receptor (2VT4), β 2 -adrenergic receptor (2RH1), D3 dopamine receptor (3PBL), H1 histamine receptor (3RZE), M2 muscarinic receptor (3UON), M3 muscarinic receptor (4DAJ), CXCR4 chemokine receptor (3ODU), CCR5 chemokine receptor (4MBS), κ -opioid receptor (4DJH), μ -opioid receptor (4DKL), nociceptin receptor (4EA3), δ -opioid receptor (4EJ4), orexin 2 receptor (4S0V), angiotensin II type 1 receptor (4YAY), protease activated receptor 1 (3VW7), sphingosine 1P receptor (3V2Y), lysophosphatidic acid receptor 1 (4Z36), adenosine A2A receptor (3EML), and P2Y 1 receptor (4XNV).
There are active-state structures for the following GPCRs: rhodopsin bound to a peptide resembling the C terminus of transducin (PDB accession code 3PQR) or bound to arrestin (4ZWJ), adenosine A2A receptor (2YDV), β 2 -adrenergic receptor bound to the G protein Gs (3SN6), M2 muscarinic receptor bound to a G protein mimetic nanobody (4MQS), μ -opioid receptor bound to a G protein mimetic nanobody (5C1M), and viral US28 bound to a G protein mimetic nanobody (4XT1).
There are agonist-bound structures of four GPCRs: β 1 -adrenergic receptor (PDB accession code 2Y01), serotonin 1B receptor (4IAQ), serotonin 2B receptor (4IB4) and neurotensin 1 receptor (4GRV). The β 1 -adrenergic receptor structure (2Y01) is nearly identical to its inactive state structure in the G-protein-coupling region and is in an agonist-bound-inactive conformation. Since there are no antagonist-or inverse-agonist-bound structures of serotonin 1B receptor, serotonin 2B receptor and neurotensin 1 receptor, their agonist-bound structures (4IAQ, 4IB4, and 4GRV) cannot be reliably classified as in an inactive state or an active state. As a result these structures were excluded.
There are three structures of the P2Y12 receptor (PDB accession codes 4NTJ, 4PXZ and 4PY0). 4PXZ and 4PY0 are similar to each other, and have a distorted TM6 (in the cytoplasmic side) owing to the fusion with BRIL (the helix 'ends' right after 6x36, becoming a short unstructured region that links to BRIL). 4NTJ is also unusual as the fusion protein still distorts the cytoplasmic region near 6x36 but the ligand binds in a peculiar pose that forces TM6 to move away from the transmembrane bundle at the extracellular side. This modifies the rest of the helix, including the cytoplasmic side. This peculiar binding pose renders most of the extracellular domain invisible, including the conserved cysteine bridge between TM3 and extracellular loop 2. Thus, due to the specific fusion splice points (in 4NTJ, 4PXZ and 4PY0) and the peculiar binding mode of the ligand (in 4NTJ), the cytoplasmic side of TM6 in the P2Y12 receptor crystal structures appears distorted and, therefore, these structures were excluded. Similarly, TM7 of FFAR1 (4PHU) is shorter than in other class A GPCRs and appears to be truncated so this receptor was also excluded. Calculation of residue contacts. We defined a residue contact between a pair of residues as present when the distance between any two atoms from the residue pair is less than the sum of their van der Waals radii plus a cut-off distance of 0.5 Å. Contacts involving the backbone atoms between residues that are less than four amino acids apart in the protein sequence were ignored to exclude local contacts 4, 14 . We only considered contacts mediated by the residues of TM1-7 or the amphipathic helix 8 (H8) (based on the GPCRdb numbering scheme), as ligand binding primarily leads to reorganization in the transmembrane bundle, and as the loops and termini are highly variable in length, structure and intrinsic disorder among the different GPCRs 30 . While rearrangements of water-mediated contacts have been shown to be important for receptor activation 10, 31 , they are not considered here because not all structures have water molecules resolved in their coordinates. In each structure, residues present in the TM1-7 or in H8 are treated as nodes, and the presence of atomic contacts between pairs of residues are treated as edges connecting the nodes. We then evaluated the presence of residue contacts between topologically equivalent residues across GPCR structures. Structural equivalence was assigned using the GPCRdb numbering scheme 20 from GPCRdb 18 .
Contact fingerprinting.
The functional importance of a given residue contact across a group of proteins can be estimated based on the extent to which topologically equivalent contacts are maintained consistently 4, 14 . For every residue contact within the ensemble, the presence or absence of an equivalent residue contact between topologically equivalent positions across the rest of the GPCR structures was recorded. This information is stored as a bit string of ones (present) and zeros (absent), which are referred to here as 'contact fingerprints' . Identifying contact fingerprints that represent consistently maintained residue contacts across and between conformational states enabled us to identify the conserved rearrangements of residue contacts in class A GPCRs. For the identification of residue contacts that are specific either to the inactive or the active states, we focused only on the GPCRs that had structures determined in both the inactive as well as active state. For the analysis of contacts across GPCRs including the inactive-and active-stateonly structures (Fig. 4b) , the contact distance threshold was computed based on the sum of the van der Waals radii of atoms plus multiple cut-off distance between 0.5 Å and 0.8 Å, in order to account for variation in the quality of structures. Sequence analysis. The alignment of 311 non-olfactory, class A human GPCRs were obtained from the GPCRdb 18 . A total of 285 positions, spanning all seven transmembrane segments and H8, were aligned. The percentage presence of amino acids for residues at positions 3x46, 6x37 and 7x53 was calculated from this alignment. The set of large hydrophobic or aromatic residues was defined to include the following amino acids: Val, Leu, Ile, Met, Phe, Tyr, and Trp. The odds of finding large hydrophobic or aromatic residues at both positions that form a contact across class A GPCRs was calculated as P/(1 − P); where P = probability of large hydrophobic or aromatic residues in both positions that mediate a contact. Structure analysis and visualization. Computer scripts used for identifying and comparing residue contacts in protein structures were written in Perl. For code availability, please contact the authors. Visualization of protein structures and residue interaction networks was performed using PyMOL (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC.). Signalling profile of Vasopressin V2 receptor mutants using BRET-based biosensors. Vasopressin V2 receptor construct used in the experiments. The human vasopressin V2 receptor construct included the N-terminal SNAP-tag for easy detection and quantification and Twin-Strep tag for optional purification in pcDNA4/TO vector (SNAP-TS-V2R). The mutations were introduced using a two-fragment PCR approach followed by Gibson assembly 32 and confirmed by sequencing. Vasopressin V2 receptor ligands.
[Arg8]-Vasopressin (Cys-Tyr-Phe-Gln-AsnCys-Pro-Arg-Gly-NH 2 ; disulfide bridge: Cys1-Cys6) was purchased from Genemed Synthesis Inc. The ligand dilutions were prepared in PBS with 0.1% (w/v) BSA. Stock solutions were stored at − 20 °C and dilutions were freshly prepared for each experiment. Biosensor constructs. For the plasmids encoding the RlucII-Gα constructs, Renilla luciferase (RlucII) was inserted into the coding sequence of human Gα s and Gα q constructs at positions 117 and 118, respectively. Gγ 1 was N-terminally tagged with GFP10 as described 22 . Untagged Gβ 1 was used for all experiments. Cell culture and transfection. Human embryonic kidney (HEK) 293SL cells were transiently co-transfected with SNAP-TS-V2R, different RlucII-Gα variants, Gβ 1 and GFP10-Gγ 1 for G protein activation measurements. HEK 293SL cells were obtained from the laboratory of Prof. Stephane Laporte, McGill University. They are clonal isolates from HEK293 cells originally obtained from ATCC. Morphology and gene expression profiles validate their identity. Mycoplasma testing is done on a routine basis for all cell and only cells free of Mycoplasma are used for experiments. Linear 25 kDa polyethylenimine (PEI) (Polysciences Inc.) was prepared in phosphate-buffered saline (PBS) (Multicell) (PEI:DNA ratio 3:1). The cells were seeded into white Cellstar PS 96-well cell culture plates (Greiner Bio-One) at a density of 20,000 cells per well and grown for 48 h at 37 °C with 5% CO 2 . Biosensor measurements. At 48 h after transfection the 96-well plates were washed once with 200 μ l PBS per well and 90 μ l of Tyrode's buffer (NaCl 137 mM, KCl 0.9 mM, MgCl 2 1 mM, NaHCO 3 11.9 mM, NaH 2 PO 4 3.6 mM, HEPES 25 mM, glucose 5.5 mM, CaCl 2 1 mM, pH 7.4) were added for measurements. The cells were stored at 37 °C with 5% CO 2 for 2 h before the measurement. The plates were incubated with 10 μ l ligand or vehicle per well for 5 min, then the luciferase substrate, coelenterazine 400a (DeepBlueC), was added to a final concentration of 2.5 μ M. After a further 5 min of incubation, luminescence and GFP10 fluorescence were measured at 410 ± 40 nm and 515 nm ± 15 nm respectively, in a Synergy Neo plate reader (Biotek) using 0.4 s integration time.
BRET was expressed as a ratio of the emission at 515 nm over the emission at 410 nm.
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Quantification of expression levels. SNAP-TS-V2R wild-type-and mutantexpressing HEK293SL cells were labelled with 50 μ l 1 μ M SNAP-Surface Alexa Fluor 647 dye (New England Biolabs Inc.) in complete medium (DMEM, 10% FBS, Penicillin-Streptomycin) for 30 min at 37 °C, 5% CO 2 in 96-well plates. The wells were each washed with 100 μ l of complete medium three times, and once with PBS. For measurements, 90 μ l Tyrode's buffer were added to each well. Fluorescence was measured with 630 nm excitation and 670 nm emission.
